Ou 1h avant l'exercice: 4 glules
JAMA Psychiatry 70 , 107120 (2013)
The one-minute breakdown The Problem The Drug: Dapiglutide The Data: About 11.6 percent weight loss The Verdict: In a market defined by #Novo and #Lilly, OK is not survivable The Cost: To prove a unique leaky gut inflammation mechanism, Zealand would need long, complex, expensive trials The Truth: It was not a bad drug
Another retrospective, multicentre cohort study, including 6201 patients with UC and 3857 patients with CD, showed better disease-related outcomes such as reduced hospitalization, surgery, intestinal fistulae and mortality in the GLP1RA cohort compared to controls [23]
doi: 10.3390/antiox1005072
Poison center calls related to GLP-1 drugs are increasing due to their popularity and increased use for weight loss